A New Biotech ETF Could Challenge Established Rivals
June 03, 2015 at 11:30 AM EDT
It has been a stellar run for the legacy biotechnology exchange traded funds. The legacy biotechnology ETFs, including the largest, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), are the five funds that prior to late last year, had no non-leveraged competition. Other members of the...
